Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition [Phase 2]
Phase 2 trial evaluating whether an antibody-mediated IL-6 inhibition reduces inflammation in patients with advanced chronic kidney disease.…
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Vascular Risk After Kidney Transplantation
Clinical trial update reporting vascular risk after kidney transplantation with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease [Phase 4]
Phase 4 trial evaluating denosumab on bone and vascular metabolism in osteoporotic chronic kidney disease; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease [Phase 2]
Phase 2 trial investigating eGFR slope as a risk marker for rapid kidney function decline in chronic kidney disease; study terminated with r…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: SVF (Adipose Tissue Derived MSC) Based Therapy for CKD. [Phase 1, Phase 2]
Clinical trial update for adipose tissue–derived mesenchymal stem cell therapy (SVF) in chronic kidney disease, spanning Phase 1 and Phase 2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) [Phase 3]
The EMPA-KIDNEY Phase 3 trial evaluating empagliflozin for heart and kidney protection in chronic kidney disease has completed with results …
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) [Phase 2]
Phase 2 trial updates for daprodustat (PHI) in anemia of CKD (ASCEND: Fe) have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Bicarbonate Administration in CKD [NA]
Clinical trial update on bicarbonate administration in chronic kidney disease with metabolic acidosis; the study is completed and results po…
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: The Effect of Cold Packs, Lidocaine and Flash Lights on Cannulation Pain in Hemodialysis Patients [Phase 3]
Phase 3 clinical trial evaluating cold packs, lidocaine, and flash lights to reduce cannulation pain at arteriovenous graft sites in hemodia…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease [Phase 4]
A Phase 4 trial updating on the efficiency and safety of Paxlovid in COVID-19 patients with severe chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects [Phase 2]
Phase 2 clinical trial updates the effects of sitaxsentan on proteinuria, 24-hour blood pressure, and arterial stiffness in chronic kidney d…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Blood Pressure Lowering in Dialysis (BOLD) Trial [Phase 2]
Phase 2 trial investigating blood pressure lowering strategies in patients with end-stage renal disease on dialysis; trial completed with re…
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Evaluate the Effect and Safety of Pu Yang Wan Wu Tang and Western Medicine on Chronic Kidney Disease [Phase 2, Phase 3]
A clinical trial update investigating Pu Yang Wan Wu Tang in combination with Western medicine for chronic kidney disease across Phase 2 and…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Five, Plus Nuts and Beans for Kidneys [NA]
Clinical trial update for a Johns Hopkins study on nutrition (five, plus nuts and beans) in chronic kidney disease and hypertension; study c…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure [NA]
This clinical trial update notes termination of a study evaluating the InnAVasc Graft for dialysis access in patients with kidney failure, w…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine [Phase 2]
Phase 2 clinical trial evaluating N-acetylcysteine to reduce thrombotic phenotype in chronic kidney disease patients; the study is completed…
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease [Phase 2]
Phase 2 clinical trial investigating atorvastatin with alkali therapy in autosomal dominant polycystic kidney disease and chronic kidney dis…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome [Phase 3]
A Phase 3 trial comparing extended-release exenatide with placebo in diabetic patients with Type 4 cardiorenal syndrome has completed enroll…
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function. [Phase 1]
Phase 1 study assessing the pharmacokinetics and safety of apraglutide in participants with normal and impaired kidney function (Chronic Kid…
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol [Phase 1]
Phase 1 study in healthy subjects evaluating drug availability of four formulations of verinurad and allopurinol.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels. [Phase 2]
Phase 2 trial evaluating the safety and efficacy of the highest tolerated dose of runcaciguat in adults with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetics study evaluating verinurad and allopurinol in combination with cyclosporine and rifampicin in healthy volunteers wi…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Assessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease [NA]
A completed clinical trial exploring the feasibility of N-of-1 trials in pediatric patients with hypertension and chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Gabapentin Versus Loratadine in Uremic Pruritus [Phase 4]
A Phase 4 trial comparing gabapentin to loratadine for uremic pruritus has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis [Phase 3]
Phase 3 trial update for Pegol-Sihematide in anemia associated with chronic kidney disease on dialysis.